BRCA Mutations Treatment Market Size

BRCA Mutations Treatment Market size was valued at USD 13 Million in 2023 and is anticipated to exceed USD 23 Billion by the end of 2036, registering over 3% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of BRCA mutations treatment is evaluated at USD 15 Million.

The increasing prevalence of cancer patients globally will exponentially propel the growth of the BRCA mutations treatment market by the end of 2036. According to WHO, 20 million new examples of cancer and 9.7 million deaths from the disease are assumed for 2022. 53.5 million people were assumed to still live their lives five years after receiving a cancer diagnosis. One in five people will have cancer at some point in their lives; one in nine men and one in twelve women will die from the sickness.